PF221 MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME
E. Onecha De La Fuente,Y. Ruiz Heredia,M. Linares Gomez,D. Martínez-Cuadrón,I. Rapado,P. Martinez Sanchez, A. Juarez Rufian,C. Sargas Simarro,B. Boluda, E. Acuña,I. Cano,P. Montesinos,E. Barragan,J.L. Rojas,J. Gorrochategui,J. Ballesteros,J. Martinez Lopez,R. Ayala Diaz HemaSphere（2019）
AI 理解论文
溯源树
样例
